NEW YORK (GenomeWeb News) — Compugen yesterday reported it earned no revenues for the second quarter of 2007, while R&D spending was down 15 percent and net loss was cut 11 percent.
 
The company reported $5,000 in revenue for the second quarter of 2006.           .
 
Compugen said R&D spending in the quarter dipped to $2.3 million from $2.7 million year over year.
 
Net loss was lowered slightly to $3.2 million from $3.6 million over the same quarter last year.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.